BrainsWay Ltd. (NASDAQ:BWAY) Q1 2023 Earnings Call May 17, 2023 8:30 AM ET

Company Participants

Brian Ritchie - Investor Relations, LifeSci Advisors

Hadar Levy - Chief Executive Officer

Scott Areglado - Senior Vice President and Chief Financial Officer

Conference Call Participants

Steve Lichtman - Oppenheimer

Jeffery Cohen - Ladenburg Thalmann

Glenn Shell - Raymond James

Carl Byrnes - Northland Capital Markets

Boobalan Pachaiyappan - H.C. Wainwright

Operator

Greetings, and welcome to the BrainsWay First Quarter 2023 Earnings Call. At this time, all participants are in a listen-only mode. A question-and-answer session will follow the formal presentation. [Operator Instructions]. As a reminder, this conference is being recorded.

I would now like to turn the conference over to your host, Brian Ritchie with LifeSci Advisors. Thank you. You may begin.

Brian Ritchie

Thank you all, and welcome to BrainsWay’s first quarter 2023 earnings conference call. With us today are BrainsWay's Chief Executive Officer, Hadar Levy, and Chief Financial Officer, Scott Areglado.

The format for today's call will be a discussion of recent trends and business updates from Hadar, followed by a detailed discussion of the financials from, Scott. Then we will open up the call for your questions.

Earlier today, BrainsWay released financial results for the three months ended March 31, 2023. A copy of the press release is available on the Company's Investor Relations website.

Before I turn the call over to Hadar and Scott, I would like to remind you that this conference call, including both management's prepared remarks and the question-and-answer session, may contain projections or other forward-looking statements regarding among other topics, BrainsWay’s anticipated future operating and financial performance, business plans and prospects, and expectations for its products and pipeline, which are all subject to risks and uncertainties, including shifting market conditions resulting from the COVID-19 pandemic, the global supply chain crisis, as well as the use of non-GAAP financial information.

Additional information regarding these and other risks are available in the Company's earnings release and its other filings with the SEC, including the Risk Factors section contained in BrainsWay’s Form 20-F.

I would now like to turn the call over to, Hadar.

Hadar Levy

Thank you, Brian. Welcome, everyone, and thank you for joining us today. We remain focused on implementing key initiatives aimed at growing the Company's topline while simultaneously advancing toward profitability. We continue to optimize our existing commercial process including enhancing our emphasize on larger institutional and enterprise customers that are playing an increasingly important role within the industry.